ArticleAnnals of translational medicine2021

TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway.

Haojun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.